Posted by Michael Wonder on 19 Oct 2021
Health Canada receives submission from Pfizer-BioNTech to authorise the use of Comirnaty COVID-19 vaccine in children 5 to 11 years of age
18 October 2021 - Today, Health Canada received a submission from Pfizer-BioNTech seeking an authorisation for the use of its Comirnaty COVID-19 vaccine in children 5 to 11 years of age.
As with all COVID-19 vaccines, the Department will prioritise the review of this submission, while maintaining its high scientific standards for safety, efficacy and quality.
